TY - STD TI - Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. ID - ref1 ER - TY - JOUR AU - Siegel, R. AU - Desantis, C. AU - Jemal, A. PY - 2014 DA - 2014// TI - Colorectal cancer statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21220 DO - 10.3322/caac.21220 ID - Siegel2014 ER - TY - JOUR AU - Si, Y. AU - Lee, J. -. I. AU - Kim, S. -. H. AU - Kim, J. -. H. AU - Kim, H. J. AU - Lee, Y. S. AU - Cho, H. M. AU - Kim, J. G. AU - Oh, S. T. AU - Lee, I. K. PY - 2010 DA - 2010// TI - Clinicopathological characteristics of ovarian metastasis from colorectal Cancer JO - Journal of the Korean Surgical Society VL - 79 UR - https://doi.org/10.4174/jkss.2010.79.4.287 DO - 10.4174/jkss.2010.79.4.287 ID - Si2010 ER - TY - STD TI - Wenhua Li 1 HW, Jian Wang 3 , Fangfang LV 1 , Xiaodong Zhu 1 and Zhonghua Wang 1,4*: ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer 2012, 12:278 2012. ID - ref4 ER - TY - JOUR AU - Lee, S. J. AU - Lee, J. AU - Lim, H. Y. AU - Kang, W. K. AU - Choi, C. H. AU - Lee, J. W. AU - Kim, T. J. AU - Kim, B. G. AU - Bae, D. S. AU - Cho, Y. B. PY - 2010 DA - 2010// TI - Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis JO - Cancer Chemother Pharmacol VL - 66 UR - https://doi.org/10.1007/s00280-009-1150-2 DO - 10.1007/s00280-009-1150-2 ID - Lee2010 ER - TY - STD TI - Qiang Feng WP, Zhao-Xu Zheng, Jian-Jun Bi, Xing-Hua Yuan: Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis. Cancer Biol Med 2013;10:86–91 2013. ID - ref6 ER - TY - STD TI - a1 OMNRLHe: The ErbB signaling network:receptor heterodimerization in development and cancer EMBO J,2000,19(13):3159—3167. 2000. ID - ref7 ER - TY - JOUR AU - Rego, R. L. AU - Foster, N. R. AU - Smyrk, T. C. AU - Le, M. AU - O'Connell, M. J. AU - Sargent, D. J. AU - Windschitl, H. AU - Sinicrope, F. A. PY - 2010 DA - 2010// TI - Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605473 DO - 10.1038/sj.bjc.6605473 ID - Rego2010 ER - TY - STD TI - Lee W-S, Jeong Heum B, Jung Nam L, Woon Kee L: Mutations in K-ras and epidermal growth factor receptor expression in Korean patients with stages III and IV colorectal Cancer. Int J Surg Pathol 2011, 19(2):145–151. ID - ref9 ER - TY - JOUR AU - Cappuzzo, F. AU - Finocchiaro, G. AU - Rossi, E. AU - Janne, P. A. AU - Carnaghi, C. AU - Calandri, C. AU - Bencardino, K. AU - Ligorio, C. AU - Ciardiello, F. AU - Pressiani, T. PY - 2007 DA - 2007// TI - EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdm492 DO - 10.1093/annonc/mdm492 ID - Cappuzzo2007 ER - TY - JOUR AU - Sawada, K. AU - Nakamura, Y. AU - Yamanaka, T. AU - Kuboki, Y. AU - Yamaguchi, D. AU - Yuki, S. AU - Yoshino, T. AU - Komatsu, Y. AU - Sakamoto, N. AU - Okamoto, W. PY - 2018 DA - 2018// TI - Prognostic and predictive value of HER2 amplification in patients with metastatic colorectal Cancer JO - Clin Colorectal Cancer VL - 17 UR - https://doi.org/10.1016/j.clcc.2018.05.006 DO - 10.1016/j.clcc.2018.05.006 ID - Sawada2018 ER - TY - STD TI - Siena S, Sartore-Bianchi A, Marsoni S, Hurwitz HI, McCall SJ, Penault-Llorca F, Srock S, Bardelli A, Trusolino L: Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018, 29(5):1108–1119. ID - ref12 ER - TY - JOUR AU - Ruschoff, J. AU - Hanna, W. AU - Bilous, M. AU - Hofmann, M. AU - Osamura, R. Y. AU - Penault-Llorca, F. AU - Vijver, M. AU - Viale, G. PY - 2012 DA - 2012// TI - HER2 testing in gastric cancer: a practical approach JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc VL - 25 UR - https://doi.org/10.1038/modpathol.2011.198 DO - 10.1038/modpathol.2011.198 ID - Ruschoff2012 ER - TY - JOUR AU - Richman, S. D. AU - Southward, K. AU - Chambers, P. AU - Cross, D. AU - Barrett, J. AU - Hemmings, G. AU - Taylor, M. AU - Wood, H. AU - Hutchins, G. AU - Foster, J. M. PY - 2016 DA - 2016// TI - HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials JO - J Pathol VL - 238 UR - https://doi.org/10.1002/path.4679 DO - 10.1002/path.4679 ID - Richman2016 ER - TY - JOUR AU - Ingold Heppner, B. AU - Behrens, H. M. AU - Balschun, K. AU - Haag, J. AU - Kruger, S. AU - Becker, T. AU - Rocken, C. PY - 2014 DA - 2014// TI - HER2/neu testing in primary colorectal carcinoma JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.483 DO - 10.1038/bjc.2014.483 ID - Ingold Heppner2014 ER - TY - JOUR AU - Valtorta, E. AU - Martino, C. AU - Sartore-Bianchi, A. AU - Penaullt-Llorca, F. AU - Viale, G. AU - Risio, M. AU - Rugge, M. AU - Grigioni, W. AU - Bencardino, K. AU - Lonardi, S. PY - 2015 DA - 2015// TI - Assessment of a HER2 scoring system for colorectal cancer: results from a validation study JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc VL - 28 UR - https://doi.org/10.1038/modpathol.2015.98 DO - 10.1038/modpathol.2015.98 ID - Valtorta2015 ER - TY - STD TI - Shan L, Lv Y, Bai B, Huang X, Zhu H. Variability in HER2 expression between primary colorectal cancer and corresponding metastases. J Cancer Res Clin Oncol. 2018. ID - ref17 ER - TY - STD TI - Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P et al: Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Annals of oncology : official journal of the European Society for Medical Oncology 2014, 25(10):1995–2001. ID - ref18 ER - TY - JOUR AU - Nam, S. K. AU - Yun, S. AU - Koh, J. AU - Kwak, Y. AU - Seo, A. N. AU - Park, K. U. AU - Kim, D. W. AU - Kang, S. B. AU - Kim, W. H. AU - Lee, H. S. PY - 2016 DA - 2016// TI - BRAF, PIK3CA, and HER2 oncogenic alterations according to KRAS mutation status in advanced colorectal cancers with distant metastasis JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0151865 DO - 10.1371/journal.pone.0151865 ID - Nam2016 ER - TY - JOUR AU - Osako, T. AU - Miyahara, M. AU - Uchino, S. AU - Inomata, M. AU - Kitano, S. AU - Kobayashi, M. PY - 1998 DA - 1998// TI - Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival JO - Oncology VL - 55 UR - https://doi.org/10.1159/000011911 DO - 10.1159/000011911 ID - Osako1998 ER - TY - JOUR AU - Kapitanovic, S. AU - Radosevic, S. AU - Kapitanovic, M. AU - Andelinovic, S. AU - Ferencic, Z. AU - Tavassoli, M. AU - Primorac, D. AU - Sonicki, Z. AU - Spaventi, S. AU - Pavelic, K. PY - 1997 DA - 1997// TI - The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer JO - Gastroenterology VL - 112 UR - https://doi.org/10.1016/S0016-5085(97)70120-3 DO - 10.1016/S0016-5085(97)70120-3 ID - Kapitanovic1997 ER - TY - JOUR AU - Kruszewski, W. J. AU - Rzepko, R. AU - Ciesielski, M. AU - Szefel, J. AU - Zielinski, J. AU - Szajewski, M. AU - Jasinski, W. AU - Kawecki, K. AU - Wojtacki, J. PY - 2010 DA - 2010// TI - Expression of HER2 in colorectal cancer does not correlate with prognosis JO - Dis Markers VL - 29 UR - https://doi.org/10.1155/2010/109063 DO - 10.1155/2010/109063 ID - Kruszewski2010 ER - TY - JOUR AU - Martin, V. AU - Landi, L. AU - Molinari, F. AU - Fountzilas, G. AU - Geva, R. AU - Riva, A. AU - Saletti, P. AU - Dosso, S. AU - Spitale, A. AU - Tejpar, S. PY - 2013 DA - 2013// TI - HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.4 DO - 10.1038/bjc.2013.4 ID - Martin2013 ER - TY - STD TI - Metges J, Gamelin E, Volant A, Capitain O, Ramee J, Raoul J, Douillard J, Etienne P, Cumin I, Dupuis O: EGFR expression is unreliable to decide for Cetuximab treatment in patients with metastatic colorectal Cancer: results from “ERBITUX-OUEST”. Open Journal of Internal Medicine 2016, 06(02):56–67. ID - ref24 ER - TY - JOUR AU - Bibeau, F. AU - Boissiere-Michot, F. AU - Sabourin, J. C. AU - Gourgou-Bourgade, S. AU - Radal, M. AU - Penault-Llorca, F. AU - Rochaix, P. AU - Arnould, L. AU - Bralet, M. P. AU - Azria, D. PY - 2006 DA - 2006// TI - Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray JO - Virchows Archiv : an international journal of pathology VL - 449 UR - https://doi.org/10.1007/s00428-006-0247-9 DO - 10.1007/s00428-006-0247-9 ID - Bibeau2006 ER -